Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Stock Information for CDT Equity Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CDT Equity Inc.

CDT Equity Increases Bitcoin Holding
CDT Equity Inc. Announces Reverse Stock Split
CDT Executes Cryptocurrency Treasury Reserve Strategy
CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
Conduit to Change Name to CDT Equity Inc.
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.